Literature DB >> 22411749

A general method to determine sampling windows for nonlinear mixed effects models with an application to population pharmacokinetic studies.

Lee Kien Foo1, James McGree, Stephen Duffull.   

Abstract

Optimal design methods have been proposed to determine the best sampling times when sparse blood sampling is required in clinical pharmacokinetic studies. However, the optimal blood sampling time points may not be feasible in clinical practice. Sampling windows, a time interval for blood sample collection, have been proposed to provide flexibility in blood sampling times while preserving efficient parameter estimation. Because of the complexity of the population pharmacokinetic models, which are generally nonlinear mixed effects models, there is no analytical solution available to determine sampling windows. We propose a method for determination of sampling windows based on MCMC sampling techniques. The proposed method attains a stationary distribution rapidly and provides time-sensitive windows around the optimal design points. The proposed method is applicable to determine sampling windows for any nonlinear mixed effects model although our work focuses on an application to population pharmacokinetic models.
Copyright © 2012 John Wiley & Sons, Ltd.

Mesh:

Substances:

Year:  2012        PMID: 22411749     DOI: 10.1002/pst.1509

Source DB:  PubMed          Journal:  Pharm Stat        ISSN: 1539-1604            Impact factor:   1.894


  4 in total

1.  A limited sampling strategy based on maximum a posteriori Bayesian estimation for a five-probe phenotyping cocktail.

Authors:  Thu Thuy Nguyen; Henri Bénech; Alain Pruvost; Natacha Lenuzza
Journal:  Eur J Clin Pharmacol       Date:  2016-01       Impact factor: 2.953

2.  Simplification of a pharmacokinetic model for red blood cell methotrexate disposition.

Authors:  Shan Pan; Julia Korell; Lisa K Stamp; Stephen B Duffull
Journal:  Eur J Clin Pharmacol       Date:  2015-09-26       Impact factor: 2.953

3.  A sequential Monte Carlo approach to derive sampling times and windows for population pharmacokinetic studies.

Authors:  J M McGree; C C Drovandi; A N Pettitt
Journal:  J Pharmacokinet Pharmacodyn       Date:  2012-07-31       Impact factor: 2.745

4.  The effect of Fisher information matrix approximation methods in population optimal design calculations.

Authors:  Eric A Strömberg; Joakim Nyberg; Andrew C Hooker
Journal:  J Pharmacokinet Pharmacodyn       Date:  2016-11-01       Impact factor: 2.745

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.